Alicia Annamalay, Senior Director of Monitoring and Evaluation at The Max Foundation, shared by Lutz Hegemann, President of Global Health and Swiss Country Affairs at Novartis, on LinkedIn:
“Proud to see this 25-year partnership recognized. Novartis’ commitment to expanding access in partnership with The Max Foundation shows what long-term collaboration can make possible for patients and health systems.
A lot has been achieved, and there is still much more to do.”
Quoting Lutz Hegemann:
“The world has seen extraordinary progress in cancer treatment over the past decades. However, access to medicines and care remains largely unequal, and where a patient lives still too often determines whether they can benefit from these advances.
For 25 years, Novartis and The Max Foundation have worked together to expand access to cancer care in low- and middle-income countries, reaching more than 100,000 patients across 71 countries.
While this strong partnership has come a long way, our work is far from finished. As we look forward, we are committed to going further, ensuring that advances in medicine reach more patients, in more places.
My sincere thanks to Pat Garcia-Gonzalez and everyone at The Max Foundation, for showing what is possible when organizations come together around a shared commitment to patients.”
Read more about our impactful partnership here .